$4.83 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 104 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 104.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WINT | Exit | WINDTREE THERAPEUTICS INC | $0 | – | -20,148 | -100.0% | 0.00% | – |
| SRSAW | Exit | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $0 | – | -333,333 | -100.0% | 0.00% | – |
| TMPMW | Exit | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $0 | – | -250,000 | -100.0% | 0.00% | – |
| OHPAW | Exit | ORION ACQUISITION CORP*w exp 02/19/202 | $0 | – | -125,000 | -100.0% | 0.00% | – |
| REVHW | Exit | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $0 | – | -200,000 | -100.0% | 0.00% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | 0 | +100.0% | 0.00% | – |
| SRSAU | Exit | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | -1 | -100.0% | 0.00% | – |
| IGNYW | Exit | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $0 | – | -362,500 | -100.0% | -0.00% | – |
| DCTH | Exit | DELCATH SYS INC | $0 | – | -486,068 | -100.0% | -0.03% | – |
| PROF | Exit | PROFOUND MED CORP | $0 | – | -732,543 | -100.0% | -0.06% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -250,000 | -100.0% | -0.06% | – |
| QSI | Exit | QUANTUM SI INC | $0 | – | -1,400,000 | -100.0% | -0.08% | – |
| HOWL | Exit | WEREWOLF THERAPEUTICS INC | $0 | – | -958,125 | -100.0% | -0.09% | – |
| OHPA | Exit | ORION ACQUISITION CORP | $0 | – | -500,000 | -100.0% | -0.10% | – |
| INZY | Exit | INOZYME PHARMA INC | $0 | – | -2,090,436 | -100.0% | -0.11% | – |
| IGNY | Exit | IGNYTE ACQUISITION CORP | $0 | – | -725,000 | -100.0% | -0.14% | – |
| TMPM | Exit | TURMERIC ACQUISITION CORPcl a | $0 | – | -750,000 | -100.0% | -0.15% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -1,000,000 | -100.0% | -0.15% | – |
| PHVS | Exit | PHARVARIS N V | $0 | – | -1,104,552 | -100.0% | -0.17% | – |
| REVH | Exit | REVOLUTION HEALTHCAR AQ CORP | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| SNRH | Exit | SENIOR CONNECT ACQUISITN COR | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| MTAC | Exit | MEDTECH ACQUISITION CORP | $0 | – | -999,999 | -100.0% | -0.20% | – |
| SRSA | Exit | SARISSA CAPITAL ACQUISITN COcl a | $0 | – | -999,999 | -100.0% | -0.20% | – |
| EUCR | Exit | EUCRATES BIOMEDICAL ACQUISIT | $0 | – | -999,999 | -100.0% | -0.20% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -484,947 | -100.0% | -0.22% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -2,390,297 | -100.0% | -0.23% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -2,021,000 | -100.0% | -0.23% | – |
| Exit | AN2 THERAPEUTICS INC | $0 | – | -716,538 | -100.0% | -0.25% | – | |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -870,000 | -100.0% | -0.28% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -2,677,500 | -100.0% | -0.32% | – |
| ISEE | Exit | IVERIC BIO INCcall | $0 | – | -1,000,000 | -100.0% | -0.36% | – |
| Exit | NOVAVAX INCnote 3.750% 2/0 | $0 | – | -25,000,000 | -100.0% | -0.48% | – | |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -75,000 | -100.0% | -0.49% | – |
| VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -0.51% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -2,414,897 | -100.0% | -0.53% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -813,112 | -100.0% | -0.78% | – |
| Exit | NEVRO CORPnote 2.750% 4/0 | $0 | – | -42,000,000 | -100.0% | -0.79% | – | |
| Exit | OAK STR HEALTH INCnote 3/1 | $0 | – | -68,000,000 | -100.0% | -1.04% | – | |
| LUNG | Exit | PULMONX CORP | $0 | – | -3,720,901 | -100.0% | -1.23% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -4,855,005 | -100.0% | -1.46% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -330,000 | -100.0% | -1.75% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -1,537,539 | -100.0% | -1.89% | – |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -88,657,000 | -100.0% | -2.95% | – | |
| Exit | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $0 | – | -174,372,000 | -100.0% | -3.40% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.